Effect of oat intake on glycaemic control and insulin sensitivity: a meta-analysis of randomised controlled trials (Q35161235)

6 August 2017

0 references

Effect of oat intake on glycaemic control and insulin sensitivity: a meta-analysis of randomised controlled trials (English)

1 reference

6 August 2017

Lei Bao

1

1 reference

6 August 2017

Xiaxia Cai

series ordinal

2

1 reference

6 August 2017

Meihong Xu

series ordinal

3

1 reference

6 August 2017

Yong Li

series ordinal

4

1 reference

6 August 2017

30 April 2014

1 reference

British Journal of Nutrition

6 August 2017

1 reference

6 August 2017

112

1 reference

6 August 2017

457-466

1 reference

6 August 2017

3

1 reference

Oat bran concentrate bread products improve long-term control of diabetes: a pilot study

6 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and streptozotocin toxicity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Chemical characterization of the avenanthramide-rich extract from oat and its effect on D-galactose-induced oxidative stress in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Oat β-glucan increased ATPases activity and energy charge in small intestine of rats

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Products based on a high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Postprandial blood glucose response in relation to gastric emptying and satiety in healthy subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Oat gum lowers glucose and insulin after an oral glucose load

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Phytochemical and fiber components in oat varieties in the HEALTHGRAIN Diversity Screen.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Coeliac disease and oats: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Phytochemical and dietary fiber components in barley varieties in the HEALTHGRAIN Diversity Screen.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Glycemic responses of oat bran products in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Hypoglycemic effects and biochemical mechanisms of oat products on streptozotocin-induced diabetic mice.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

Oat: unique among the cereals.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114514000889

7 January 2021

10.1017/S0007114514000889

Identifiers

DOI

1 reference

6 August 2017

1 reference